UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000035379
Receipt No. R000040222
Scientific Title The Effect of test food (HBF 2018-04) on human body temperature: Parallel study
Date of disclosure of the study information 2019/01/31
Last modified on 2020/12/17 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The Effect of test food (HBF 2018-04) on human body temperature: Parallel study
Acronym The Effect of test food (HBF 2018-04) on human body temperature.
Scientific Title The Effect of test food (HBF 2018-04) on human body temperature: Parallel study
Scientific Title:Acronym The Effect of test food (HBF 2018-04) on human body temperature.
Region
Japan

Condition
Condition Healthy adult
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effect of the test food on body temperature
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 1. Body temperature
Key secondary outcomes 1. Questionnaire survey on the physical condition
2. Body composition

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Oral ingestion of the test food once a day for 30 weeks
Interventions/Control_2 Oral ingestion of the placebo food once a day for 30 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male
Key inclusion criteria 1)Healthy Japanease adult men

2)Subjects who signed the informed consent for participation in the study
Key exclusion criteria 1)Subjects with medical history of severe disorders

2)Subjects who judged as unsuitable for this study by the principal investigator for any reasons
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Chiyo
Middle name
Last name Yoshizane
Organization Hayashibara CO., LTD.
Division name R&D Division, Development Unit
Zip code 702-8006
Address 675-1, Fujisaki, Naka-ku, Okayama
TEL 086-276-3141
Email chiyo.yoshizane@hb.nagase.co.jp

Public contact
Name of contact person
1st name Chiyo
Middle name
Last name Yoshizane
Organization Hayashibara CO., LTD.
Division name R&D Division, Development Unit
Zip code 702-8006
Address 675-1, Fujisaki, Naka-ku, Okayama
TEL 086-276-3141
Homepage URL
Email chiyo.yoshizane@hb.nagase.co.jp

Sponsor
Institute Hayashibara CO., LTD.
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The Ethics Committee of Hayashibara Co., Ltd.
Address 675-1,Fujisaki, Naka-ku, Okayama, Japan
Tel 086-276-3141
Email HB96301@hb.nagase.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 株式会社林原(岡山県) / Hayashibara Co., Ltd. (Okayama)

Other administrative information
Date of disclosure of the study information
2019 Year 01 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 65
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 10 Month 26 Day
Date of IRB
2018 Year 10 Month 29 Day
Anticipated trial start date
2019 Year 02 Month 01 Day
Last follow-up date
2019 Year 10 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2018 Year 12 Month 27 Day
Last modified on
2020 Year 12 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040222